In a research report published today, Canaccord analyst Jed Dorsheimer maintained a Buy rating on shares of Canadian Solar Inc. (NASDAQ:CSIQ) and reduced the price …
Canaccord analyst John Newman weighed in today with a few insights on Kite Pharma Inc (NASDAQ:KITE), after the company informed investors that there was one …
In a research report issued yesterday, Canaccord analyst Michael Walkley reiterated a Buy rating on shares of Qualcomm, Inc. (NASDAQ:QCOM) with a $75 price target, after …
In a research report issued today, Canaccord analyst Michael Walkley reiterated a Buy rating on shares of Qorvo Inc (NASDAQ:QRVO) with a $77 price target, …
Canaccord analyst Michael Graham came out with some commentary on Glu Mobile Inc. (NASDAQ:GLUU), after the Company’s CFO Eric Ludwig made a presentation at the Canaccord Genuity Global …
In a research report issued yesterday, Canaccord analyst Matthew Ramsay reiterated a Buy rating on shares of InvenSense Inc (NYSE:INVN) with a $15 price …
Canaccord analyst John Newman was out pounding the table on Kite Pharma Inc (NASDAQ:KITE), reiterating a Buy rating and price target of $90, …
Canaccord analyst Mark Rothschild came out with some commentary on Brookfield Asset Management Inc (NYSE:BAM), after the Canadian asset management company released its second-quarter results last …
In a research report released today, Canaccord analyst Mark Rothschild provided commentary and analysis on the second-quarter earnings results of Brookfield Asset Management Inc (NYSE:BAM), which were …
Canaccord Genuity analyst John Newman came out today with some cautious stance on Agios Pharmaceuticals Inc (NASDAQ:AGIO), as the company will present data for AG-120 in …
